Drug recall · April 14, 2021
Guanfacine Extended-Release Tablets 2 mg recall
Why: Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
- Lots / codes
Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
- Quantity
- 55620 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- Nationwide within the United States
- Initiated
- March 31, 2021 · Voluntary: Firm initiated
- Classified
- April 6, 2021
- Reported
- April 14, 2021
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Guanfacine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.